What To Expect From Bristol Myers Squibb Stock After Q3 Results?

What To Expect From Bristol Myers Squibb Stock After Q3 Results?

Bristol Myers Squibb is scheduled to report its Q3 2021 results on Wednesday, October 27. We expect the company to likely post revenue and earnings slightly above the consensus estimates, primarily led by continued market share gains for its anticoagulant Eliquis, cancer drugs Opdivo and Yervoy…